Study: PET with 18F-flurpiridaz better than SPECT in CAD diagnosis

01/28/2013 | Healio

PET myocardial perfusion imaging with 18F-flurpiridaz produced better images than SPECT imaging for the diagnosis of coronary artery disease, according to a study in the Journal of the American College of Cardiology. More PET images were considered excellent or good than SPECT images, and they also had higher sensitivity, the Phase II study found. "These findings suggest that this new tracer might significantly improve the assessment of patients with radionuclide MPI compared with the standard SPECT MPI methods," researchers said.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC